Jenny Chang, MB, ChB

Publications

2 grants

PI
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
NCI · 2023–2028 · via NIH RePORTER
R01CA284315-04
MPI
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
NCI · 2022–2027 · via NIH RePORTER
U01CA268813-04

Completed grants (7)

PI
Center for Immunotherapeutic Transport Oncophysics
NCI · 2016–2022 · via NIH RePORTER
U54CA210181-05
PI
Biomimetic nanovesicles to overcome multiple physiological barriers for primary and metastatic triple negative breast cancer therapy
NCI · 2017–2020 · via NIH RePORTER
R56CA213859-01A1
PI
Targeting Notch, PI3K-AKT and Other Novel Pathways in Breast Cancer Stem Cells
NCI · 2008–2013 · via NIH RePORTER
R01CA138197-05
PI
Treatment Resistance Pathways & Targeting Residula Cancers
NCI · 2007–2013 · via NIH RePORTER
P50CA058183-18
PI
NSABP Participating Sites
NCI · 2006–2012 · via NIH RePORTER
U10CA118735-04
PI
Breast cancer response markers to a dual HER1/2 blocker
NCI · 2005–2010 · via NIH RePORTER
R01CA112305-05
PI
MECHANISM OF ACTION OF HERCEPTIN R IN BREAST CANCER
NCI · 2000–2003 · via NIH RePORTER
R21CA087649-02S1